What happens when nerve cells lose their way?

encodes a molecule that helps guide axons from the eye to the brain.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

During normal embryonic development of the zebrafish, axons of the retinal ganglion cell (RGC) navigate from the eye to a region of the brain known as the tectum. In common with other axons, retinal axons are believed to reach their target by sensing and responding to cues in their immediate environment telling them where to go and where not to go — a process called pathfinding.

In the 20 April Science Cornelia Fricke and colleagues of the Department of Neurobiology and Anatomy, University of Utah Medical Center, have identified a number of mutations in the astray (ast) gene that lead to a variety of pathfinding errors. Instead of relocating to the tectum RGC axons in ast/ast embryos are misprojected to other parts of the brain — anteriorly into the diencephalon and telencephalon, and posteriorly into the ventral hindbrain — and sometimes into the opposite eye. The axons often recrossed the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Kenneth Lee

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development